NYSE:STE - STERIS Stock Price, Price Target & More

$96.04 -0.18 (-0.19 %)
(As of 04/20/2018 04:00 PM ET)
Previous Close$96.22
Today's Range$95.78 - $96.91
52-Week Range$70.29 - $97.47
Volume228,633 shs
Average Volume359,483 shs
Market Capitalization$8.22 billion
P/E Ratio25.55
Dividend Yield1.28%
Beta1.12

About STERIS (NYSE:STE)

STERIS logoSTERIS plc develops, manufactures, and markets infection prevention, contamination control, microbial reduction, and surgical and gastrointestinal support products and services for healthcare, pharmaceutical, scientific, research, industrial, and governmental customers worldwide. The company's Healthcare Products segment offers steam, vaporized hydrogen peroxide, and ethylene oxide sterilizers, as well as liquid chemical sterilant processing systems; automated washer/disinfector systems; general and specialty surgical tables, surgical and examination lights, equipment management systems, operating room storage cabinets, warming cabinets, scrub sinks, and other accessories; and gastrointestinal devices and accessories. It also provides OR integration, OR and sterile processing department, workflow, patient tracking, and instrument management solutions; and cleaning chemistries and sterility assurance products. In addition, this segment offers preventive maintenance and repair, sterilization and surgical management consulting, and remote equipment monitoring services, as well as other support services. The company's Healthcare Specialty Services segment provides solutions, and outsourced and managed services for acute care hospitals and other healthcare settings, including instrument and endoscope repair and maintenance solutions; and custom process improvement consulting services. Its Life Sciences segment offers formulated cleaning chemistries, vaporized hydrogen peroxide generators, high-purity water equipment, steam sterilizers, and washers/disinfectors. The company's Applied Sterilization Technologies segment provides contract sterilization services using gamma, electron beam, and X-ray technologies, as well as ethylene oxide gas; and laboratory testing and validation services. It operates a network of 50 facilities. The company was founded in 1985 and is headquartered in Leicester, the United Kingdom.

Receive STE News and Ratings via Email

Sign-up to receive the latest news and ratings for STE and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical appliances & supplies
Sub-IndustryHealth Care Equipment
SectorMedical
SymbolNYSE:STE
CUSIP85915210
Phone44-13-3238-7100

Debt

Debt-to-Equity Ratio0.46%
Current Ratio2.82%
Quick Ratio2.22%

Price-To-Earnings

Trailing P/E Ratio25.55
Forward P/E Ratio23.25
P/E GrowthN/A

Sales & Book Value

Annual Sales$2.61 billion
Price / Sales3.12
Cash Flow$6.6556 per share
Price / Cash14.43
Book Value$33.08 per share
Price / Book2.90

Profitability

EPS (Most Recent Fiscal Year)$3.76
Net Income$109.96 million
Net Margins9.42%
Return on Equity11.57%
Return on Assets6.80%

Miscellaneous

Employees12,000
Outstanding Shares84,850,000

How to Become a New Pot Stock Millionaire

STERIS (NYSE:STE) Frequently Asked Questions

What is STERIS's stock symbol?

STERIS trades on the New York Stock Exchange (NYSE) under the ticker symbol "STE."

How often does STERIS pay dividends? What is the dividend yield for STERIS?

STERIS announced a quarterly dividend on Wednesday, February 7th. Stockholders of record on Wednesday, February 28th will be paid a dividend of $0.31 per share on Wednesday, March 28th. This represents a $1.24 dividend on an annualized basis and a dividend yield of 1.29%. The ex-dividend date is Tuesday, February 27th. This is a boost from STERIS's previous quarterly dividend of $0.21. View STERIS's Dividend History.

How were STERIS's earnings last quarter?

STERIS (NYSE:STE) released its earnings results on Wednesday, February, 7th. The medical equipment provider reported $1.12 earnings per share for the quarter, beating the consensus estimate of $1.07 by $0.05. The medical equipment provider had revenue of $661.90 million for the quarter, compared to analyst estimates of $663.17 million. STERIS had a return on equity of 11.57% and a net margin of 9.42%. The business's revenue was up 2.3% on a year-over-year basis. During the same period in the previous year, the company posted $0.98 EPS. View STERIS's Earnings History.

When is STERIS's next earnings date?

STERIS is scheduled to release their next quarterly earnings announcement on Tuesday, May, 8th 2018. View Earnings Estimates for STERIS.

What guidance has STERIS issued on next quarter's earnings?

STERIS issued an update on its FY18 earnings guidance on Wednesday, February, 7th. The company provided EPS guidance of $4.10-4.16 for the period, compared to the Thomson Reuters consensus estimate of $4.05.

What price target have analysts set for STE?

5 brokers have issued 12 month price targets for STERIS's stock. Their forecasts range from $16.00 to $103.00. On average, they expect STERIS's stock price to reach $80.25 in the next twelve months. View Analyst Ratings for STERIS.

Who are some of STERIS's key competitors?

Who are STERIS's key executives?

STERIS's management team includes the folowing people:
  • Mr. Walter M. Rosebrough Jr., Pres, CEO & Director (Age 64)
  • Mr. Michael J. Tokich, Sr. VP, CFO & Treasurer (Age 49)
  • Mr. John Adam Zangerle, VP, Gen. Counsel & Sec. (Age 51)
  • Mr. Daniel A. Carestio, Sr. VP of Applied Sterilization Technologies and Life Sciences (Age 45)
  • Dr. Adrian Vincent Coward, Sr. VP of Healthcare Specialty Services (Age 48)

Has STERIS been receiving favorable news coverage?

News coverage about STE stock has trended somewhat positive this week, according to Accern. The research group scores the sentiment of press coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. STERIS earned a news impact score of 0.16 on Accern's scale. They also assigned news articles about the medical equipment provider an impact score of 47.44 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company's share price in the next several days.

How do I buy shares of STERIS?

Shares of STE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is STERIS's stock price today?

One share of STE stock can currently be purchased for approximately $96.04.

How big of a company is STERIS?

STERIS has a market capitalization of $8.22 billion and generates $2.61 billion in revenue each year. The medical equipment provider earns $109.96 million in net income (profit) each year or $3.76 on an earnings per share basis. STERIS employs 12,000 workers across the globe.

How can I contact STERIS?

STERIS's mailing address is Rutherford House Stephensons Way Chaddesden, Derby X0, DE21 6LY. The medical equipment provider can be reached via phone at 44-13-3238-7100 or via email at [email protected]


MarketBeat Community Rating for STERIS (STE)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  155 (Vote Outperform)
Underperform Votes:  228 (Vote Underperform)
Total Votes:  383
MarketBeat's community ratings are surveys of what our community members think about STERIS and other stocks. Vote "Outperform" if you believe STE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe STE will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

STERIS (NYSE:STE) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
5 Wall Street analysts have issued ratings and price targets for STERIS in the last 12 months. Their average twelve-month price target is $80.25, suggesting that the stock has a possible downside of 16.44%. The high price target for STE is $103.00 and the low price target for STE is $16.00. There are currently 2 hold ratings and 3 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.602.602.502.60
Ratings Breakdown: 0 Sell Rating(s)
2 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $80.25$80.25$72.3333$87.3333
Price Target Upside: 16.44% downside4.68% downside18.09% downside3.68% downside

STERIS (NYSE:STE) Consensus Price Target History

Price Target History for STERIS (NYSE:STE)

STERIS (NYSE:STE) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/8/2018KeyCorpReiterated RatingBuy$103.00MediumView Rating Details
2/8/2018Northcoast ResearchSet Price TargetBuy$102.00MediumView Rating Details
1/3/2018Raymond JamesReiterated RatingOutperform -> Market Perform$100.00HighView Rating Details
11/9/2017TD SecuritiesBoost Price TargetBuyC$14.00 -> C$16.00N/AView Rating Details
6/5/2017Wellington ShieldsDowngradeGradually Accumulate -> HoldLowView Rating Details
11/30/2016Goldman SachsInitiated CoverageNeutral$71.00N/AView Rating Details
11/4/2016JMP SecuritiesReiterated RatingBuyN/AView Rating Details
(Data available from 4/21/2016 forward)

Earnings

STERIS (NYSE:STE) Earnings History and Estimates Chart

Earnings by Quarter for STERIS (NYSE:STE)

STERIS (NYSE:STE) Earnings Estimates

2018 EPS Consensus Estimate: $4.05
2019 EPS Consensus Estimate: $4.78
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20182$0.80$0.82$0.81
Q2 20182$0.92$0.94$0.93
Q3 20182$1.06$1.11$1.09
Q4 20182$1.22$1.22$1.22
Q1 20191$0.99$0.99$0.99
Q2 20191$1.12$1.12$1.12
Q3 20191$1.28$1.28$1.28
Q4 20191$1.39$1.39$1.39

STERIS (NYSE STE) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/8/2018$1.20N/AView Earnings Details
2/7/2018Q3 2018$1.07$1.12$663.17 million$661.90 millionViewN/AView Earnings Details
11/1/2017Q2 2018$0.95$0.94$629.02 million$634.20 millionViewN/AView Earnings Details
8/8/2017Q1 2018$0.80$0.85$597.66 million$608.00 millionViewListenView Earnings Details
5/9/2017Q4$1.07$1.11$673.47 million$681.20 millionViewListenView Earnings Details
2/7/2017Q317$1.04$0.98$680.13 million$646.80 millionViewListenView Earnings Details
11/2/2016Q217$0.90$0.89$670.24 million$646.40 millionViewN/AView Earnings Details
8/9/2016Q117$0.77$0.79$639.04 million$638.40 millionViewListenView Earnings Details
5/18/2016Q416$1.04$0.90$701.92 million$690.30 millionViewListenView Earnings Details
2/9/2016Q316$0.94$0.98$617.35 million$618.70 millionViewN/AView Earnings Details
10/30/2015Q216$0.76$0.83$488.66 million$489.90 millionViewListenView Earnings Details
8/4/2015Q415$0.61$0.62$439.23 million$439.90 millionViewListenView Earnings Details
5/7/2015Q4$0.89$0.98$520.07 million$501.60 millionViewListenView Earnings Details
2/4/2015Q315$0.73$0.79$475.22 million$473.20 millionViewListenView Earnings Details
11/4/2014Q215$0.62$0.68$452.50 million$462.70 millionViewListenView Earnings Details
8/5/2014Q115$0.54$0.54$418.26 million$412.60 millionViewListenView Earnings Details
5/8/2014Q4$0.86$0.91$455.92 million$465.30 millionViewListenView Earnings Details
2/5/2014Q314$0.69$0.59$406.40 million$405.60 millionViewListenView Earnings Details
10/30/2013Q214$0.54$0.55$376.82 million$383.80 millionViewListenView Earnings Details
8/7/2013Q1 2014$0.56$0.44$372.69 million$367.70 millionViewListenView Earnings Details
5/7/2013Q4 2013$0.65$0.70$405.79 million$426.20 millionViewListenView Earnings Details
2/6/2013Q3 2013$0.56$0.58$368.84 million$380.40 millionViewListenView Earnings Details
10/31/2012Q213$0.52$0.53$350.23 million$356.30 millionViewN/AView Earnings Details
8/2/2012$0.44$0.53ViewN/AView Earnings Details
5/8/2012$0.60$0.59ViewN/AView Earnings Details
2/7/2012$0.60$0.58ViewN/AView Earnings Details
11/2/2011$0.57$0.50ViewN/AView Earnings Details
8/2/2011$0.50$0.46ViewN/AView Earnings Details
5/9/2011$0.62$0.61ViewN/AView Earnings Details
2/8/2011$0.58$0.57ViewN/AView Earnings Details
11/3/2010Q2 2011$0.54$0.55ViewN/AView Earnings Details
8/3/2010Q1 2011$0.45$0.46ViewN/AView Earnings Details
5/6/2010Q4 2010$0.53$0.55ViewN/AView Earnings Details
2/2/2010Q3 2010$0.47$0.69ViewN/AView Earnings Details
11/3/2009Q2 2010$0.43$0.54ViewN/AView Earnings Details
7/30/2009Q1 2010$0.41$0.43ViewN/AView Earnings Details
5/7/2009Q4 2009$0.38$0.49ViewN/AView Earnings Details
1/27/2009Q3 2009$0.37$0.53ViewN/AView Earnings Details
10/30/2008Q2 2009$0.34$0.48ViewN/AView Earnings Details
7/30/2008Q1 2009$0.27$0.43ViewN/AView Earnings Details
5/7/2008Q4 2008$0.50$0.59ViewN/AView Earnings Details
1/30/2008Q3 2008$0.38$0.35ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

STERIS (NYSE:STE) Dividend Information

STERIS pays an annual dividend of $1.24 per share, with a dividend yield of 1.29%. STE's most recent quarterly dividend payment was Wednesday, March 28. The company has grown its dividend for the last 8 consecutive years and is increasing its dividend by an average of 10.30% each year. STERIS pays out 32.98% of its earnings out as a dividend.
Most Recent Dividend:3/28/2018
Annual Dividend:$1.24
Dividend Yield:1.29%
Dividend Growth:10.30% (3 Year Average)
Payout Ratio:32.98% (Trailing 12 Months of Earnings)
30.02% (Based on This Year's Estimates)
26.33% (Based on Next Year's Estimates)
Track Record:8 Years of Consecutive Dividend Growth
Frequency:Quarterly Dividend
Dividend Payments by Quarter for STERIS (NYSE:STE)

STERIS (NYSE:STE) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/7/2018quarterly$0.311.35%2/27/20182/28/20183/28/2018
11/1/2017Quarterly$0.311.42%11/21/201711/22/201712/20/2017
8/8/2017Quarterly$0.311.46%8/25/20178/29/20179/28/2017
5/9/2017Quarterly$0.286/5/20176/7/20176/29/2017
2/7/2017Quarterly$0.281.67%2/24/20172/28/20173/28/2017
11/2/2016Quarterly$0.281.69%11/21/201611/23/201612/21/2016
8/9/2016Quarterly$0.281.6%8/26/20168/30/20169/27/2016
5/18/2016quarterly$0.251.43%6/6/20166/8/20166/29/2016
2/9/2016Quarterly$0.252/26/20163/1/20163/29/2016
10/19/2015quarterly$0.251.45%10/28/201510/30/201512/18/2015
8/5/2015quarterly$0.251.45%8/21/20158/25/20159/22/2015
5/7/2015quarterly$0.231.35%6/1/20156/3/20156/25/2015
2/5/2015quarterly$0.231.36%2/23/20152/25/20153/25/2015
11/5/2014quarterly$0.231.47%11/24/201411/26/201412/23/2014
8/6/2014quarterly$0.231.79%8/22/20148/26/20149/23/2014
5/14/2014quarterly$0.211.58%6/3/20146/5/20146/26/2014
2/6/2014quarterly$0.211.91%2/24/20142/26/20143/26/2014
10/30/2013$0.2111/18/201311/20/201312/18/2013
8/7/2013quarterly$0.211.91%8/26/20138/28/20139/25/2013
5/8/2013quarterly$0.191.69%5/31/20136/4/20136/25/2013
2/7/2013quarterly$0.191.93%2/25/20132/27/20133/27/2013
(Data available from 1/1/2013 forward)

Insider Trades

STERIS (NYSE STE) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 2.55%
Institutional Ownership Percentage: 89.37%
Insider Trading History for STERIS (NYSE:STE)
Institutional Ownership by Quarter for STERIS (NYSE:STE)

STERIS (NYSE STE) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/18/2018Sudhir K. PahwaVPSell1,981$97.11$192,374.91View SEC Filing  
3/12/2018Walter M Rosebrough JrCEOSell10,000$95.50$955,000.00View SEC Filing  
3/5/2018Richard Martin SteevesDirectorSell58,953$91.00$5,364,723.009,362View SEC Filing  
2/28/2018Jacqueline B KosecoffDirectorSell2,744$91.94$252,283.36View SEC Filing  
2/26/2018Cynthia L FeldmannDirectorSell3,218$91.35$293,964.3011,214View SEC Filing  
2/13/2018Karen L BurtonVPSell1,500$85.59$128,385.00View SEC Filing  
1/29/2018Sudhir K. PahwaVPSell2,000$92.09$184,180.00View SEC Filing  
11/14/2017John Adam ZangerleVPSell3,650$88.00$321,200.00View SEC Filing  
10/23/2017Michael J TokichInsiderSell11,000$92.00$1,012,000.0058,588View SEC Filing  
10/4/2017Michael J TokichInsiderSell12,000$89.75$1,077,000.00View SEC Filing  
10/4/2017Walter M Rosebrough JrCEOSell10,000$90.50$905,000.00View SEC Filing  
9/8/2017Richard Martin SteevesDirectorSell156,072$87.13$13,598,553.369,362View SEC Filing  
8/16/2017Walter M Rosebrough JrCEOSell10,000$85.69$856,900.0083,270View SEC Filing  
8/15/2017Karen L BurtonVPSell3,270$85.70$280,239.0011,807View SEC Filing  
8/9/2017Mohsen SohiDirectorSell2,744$85.98$235,929.1221,816View SEC Filing  
7/3/2017Michael B WoodDirectorSell4,000$81.50$326,000.0026,131View SEC Filing  
6/16/2017Kathleen BardwellInsiderSell3,795$82.00$311,190.0020,605View SEC Filing  
6/13/2017Daniel A. CarestioInsiderSell4,745$80.08$379,979.60View SEC Filing  
6/2/2017Walter M. Rosebrough, Jr.CEOSell10,000$80.05$800,500.00View SEC Filing  
6/1/2017Kathleen BardwellInsiderSell4,000$79.00$316,000.0020,975View SEC Filing  
6/1/2017Sudhir K PahwaVPSell3,000$79.07$237,210.0022,047View SEC Filing  
5/25/2017Sudhir K. PahwaVPSell800$77.28$61,824.00View SEC Filing  
5/9/2017Michael J TokichCFOSell13,600$76.00$1,033,600.0058,106View SEC Filing  
5/9/2017Sudhir K. PahwaVPSell200$77.00$15,400.00View SEC Filing  
5/3/2017Daniel A CarestioInsiderSell7,590$75.17$570,540.3025,390View SEC Filing  
5/3/2017John Adam ZangerleVPSell3,150$75.00$236,250.0026,639View SEC Filing  
5/3/2017Michael B WoodDirectorSell4,000$75.00$300,000.0030,131View SEC Filing  
5/3/2017Michael J TokichCFOSell2,000$75.00$150,000.0046,506View SEC Filing  
2/13/2017Mohsen SohiDirectorSell3,387$67.66$229,164.4224,421View SEC Filing  
1/17/2017Kathleen BardwellInsiderSell1,962$68.78$134,946.3616,538View SEC Filing  
12/13/2016John Adam ZangerleVPSell3,100$69.00$213,900.0026,589View SEC Filing  
12/8/2016Daniel A CarestioInsiderSell2,225$67.54$150,276.5020,025View SEC Filing  
11/15/2016John Adam ZangerleVPSell2,200$67.00$147,400.0026,166View SEC Filing  
11/4/2016Cynthia L FeldmannDirectorSell4,744$64.98$308,265.1214,581View SEC Filing  
9/7/2016Richard Martin SteevesDirectorSell204,778$71.19$14,578,145.82165,434View SEC Filing  
8/31/2016Adrian Vincent CowardInsiderSell15,000$69.00$1,035,000.00View SEC Filing  
8/26/2016Sudhir K. PahwaVPSell1,028$70.13$72,093.64View SEC Filing  
8/17/2016Walter M. Rosebrough, Jr.CEOSell15,000$71.08$1,066,200.00View SEC Filing  
8/12/2016Daniel A. CarestioInsiderSell2,681$71.04$190,458.24View SEC Filing  
2/17/2016Walter M. Rosebrough, Jr.CEOSell10,000$64.27$642,700.00View SEC Filing  
11/18/2015Walter M Rosebrough JrCEOSell11,960$75.58$903,936.80111,376View SEC Filing  
11/9/2015Kathleen BardwellinsiderSell2,496$73.85$184,329.6013,235View SEC Filing  
11/9/2015Kevin M. McmullenDirectorSell8,000$73.73$589,840.0026,338View SEC Filing  
11/3/2015Mohsen SohiDirectorSell3,000$76.36$229,080.0020,250View SEC Filing  
10/30/2015Daniel A. CarestioinsiderSell6,270$74.00$463,980.0016,800View SEC Filing  
10/28/2015Sudhir K PahwaVPSell1,000$70.09$70,090.0021,289View SEC Filing  
9/30/2015Walter M Rosebrough JrCEOSell5,000$64.92$324,600.00116,376View SEC Filing  
9/29/2015Walter M Rosebrough JrCEOSell10,000$64.43$644,300.00121,376View SEC Filing  
6/15/2015David Allen JohnsonVPSell1,826$63.08$115,184.08View SEC Filing  
6/10/2015Walter M Rosebrough JrCEOSell20,000$63.80$1,276,000.00View SEC Filing  
6/9/2015Walter M Rosebrough JrCEOSell5,000$63.56$317,800.00View SEC Filing  
8/11/2014Michael B WoodDirectorSell5,300$51.79$274,487.00View SEC Filing  
6/2/2014John Adam ZangerleVPSell2,000$53.45$106,900.00View SEC Filing  
5/12/2014John WarehamDirectorSell15,000$55.09$826,350.0023,256View SEC Filing  
4/2/2014Michael TokichCFOSell4,525$51.68$233,852.0030,320View SEC Filing  
1/8/2014Michael TokichCFOSell4,200$48.72$204,624.0030,320View SEC Filing  
11/26/2013Cynthia FeldmannDirectorSell6,254$45.97$287,496.3810,000View SEC Filing  
8/8/2013Timothy ChapmanSVPSell10,000$43.84$438,400.0021,581View SEC Filing  
6/12/2013Kevin M McmullenDirectorSell10,000$44.09$440,900.00View SEC Filing  
5/30/2013Walter M Rosebrough JrCEOSell2,000$45.72$91,440.00View SEC Filing  
5/22/2013Mohsen SohiDirectorSell10,000$45.21$452,100.00View SEC Filing  
5/21/2013William L AamothTreasurerSell6,150$45.96$282,654.00View SEC Filing  
5/13/2013David Allen JohnsonVPSell2,680$44.99$120,573.20View SEC Filing  
10/5/2012Michael J TokichCFOSell4,100$37.00$151,700.00View SEC Filing  
8/9/2012Cynthia L FeldmannDirectorSell23,122$34.05$787,304.10View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

STERIS (NYSE STE) News Headlines

Source:
DateHeadline
STERIS (STE) VP Sudhir K. Pahwa Sells 1,981 SharesSTERIS (STE) VP Sudhir K. Pahwa Sells 1,981 Shares
www.americanbankingnews.com - April 19 at 7:35 PM
STERIS (STE) Expected to Post Quarterly Sales of $709.63 MillionSTERIS (STE) Expected to Post Quarterly Sales of $709.63 Million
www.americanbankingnews.com - April 16 at 2:17 AM
BidaskClub Downgrades STERIS (STE) to BuyBidaskClub Downgrades STERIS (STE) to Buy
www.americanbankingnews.com - April 14 at 9:13 PM
$1.22 EPS Expected for STERIS (STE) This Quarter$1.22 EPS Expected for STERIS (STE) This Quarter
www.americanbankingnews.com - April 14 at 7:18 PM
Medical Instrument Stocks Head-to-Head: Abiomed vs. STERISMedical Instrument Stocks Head-to-Head: Abiomed vs. STERIS
finance.yahoo.com - April 13 at 9:29 AM
STERIS (STE) Downgraded to "Hold" at Zacks Investment ResearchSTERIS (STE) Downgraded to "Hold" at Zacks Investment Research
www.americanbankingnews.com - April 12 at 11:12 AM
Steris PLC (STE) Receives Consensus Recommendation of "Buy" from BrokeragesSteris PLC (STE) Receives Consensus Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - April 7 at 1:29 AM
KeyCorp Reaffirms "Buy" Rating for Steris (STE)KeyCorp Reaffirms "Buy" Rating for Steris (STE)
www.americanbankingnews.com - April 6 at 9:16 PM
Steris (STE) Rating Lowered to Hold at Zacks Investment ResearchSteris (STE) Rating Lowered to Hold at Zacks Investment Research
www.americanbankingnews.com - April 6 at 12:35 PM
Steris (STE) Rating Increased to Buy at Zacks Investment ResearchSteris (STE) Rating Increased to Buy at Zacks Investment Research
www.americanbankingnews.com - April 5 at 1:55 PM
Steris (STE) Rating Reiterated by KeyCorpSteris (STE) Rating Reiterated by KeyCorp
www.americanbankingnews.com - April 2 at 8:20 AM
Steris PLC (STE) Expected to Announce Quarterly Sales of $709.63 MillionSteris PLC (STE) Expected to Announce Quarterly Sales of $709.63 Million
www.americanbankingnews.com - March 30 at 1:50 AM
$1.22 EPS Expected for Steris PLC (STE) This Quarter$1.22 EPS Expected for Steris PLC (STE) This Quarter
www.americanbankingnews.com - March 28 at 11:12 PM
Steris (STE) Downgraded by Zacks Investment Research to "Hold"Steris (STE) Downgraded by Zacks Investment Research to "Hold"
www.americanbankingnews.com - March 28 at 2:41 PM
Steris (STE) Raised to "Buy" at Zacks Investment ResearchSteris (STE) Raised to "Buy" at Zacks Investment Research
www.americanbankingnews.com - March 27 at 2:54 PM
Steris Target of Unusually Large Options Trading (STE)Steris Target of Unusually Large Options Trading (STE)
www.americanbankingnews.com - March 27 at 6:54 AM
Global Low Temperature Sterilization Market Analysis & Outlook 2018-2022 Featuring Johnson & Johnson, 3M, Getinge and Steris - ResearchAndMarkets.comGlobal Low Temperature Sterilization Market Analysis & Outlook 2018-2022 Featuring Johnson & Johnson, 3M, Getinge and Steris - ResearchAndMarkets.com
www.businesswire.com - March 23 at 9:10 AM
Favorable Market Trend & Core Business Expansion Aid STERISFavorable Market Trend & Core Business Expansion Aid STERIS
www.zacks.com - March 21 at 10:14 AM
Zacks Investment Research Downgrades Steris (STE) to HoldZacks Investment Research Downgrades Steris (STE) to Hold
www.americanbankingnews.com - March 20 at 2:58 PM
The global patient positioning systems market is anticipated to reach USD 1.4 billion by 2025The global patient positioning systems market is anticipated to reach USD 1.4 billion by 2025
www.prnewswire.com - March 20 at 9:24 AM
Zacks Investment Research Upgrades Steris (STE) to BuyZacks Investment Research Upgrades Steris (STE) to Buy
www.americanbankingnews.com - March 19 at 1:45 PM
Steris Corp. Looks Bullish on Our Charts - Further Gains AheadSteris Corp. Looks Bullish on Our Charts - Further Gains Ahead
finance.yahoo.com - March 16 at 5:40 PM
Steris PLC (STE) CEO Walter M. Rosebrough, Jr. Sells 10,000 SharesSteris PLC (STE) CEO Walter M. Rosebrough, Jr. Sells 10,000 Shares
www.americanbankingnews.com - March 13 at 7:32 PM
$709.63 Million in Sales Expected for Steris PLC (STE) This Quarter$709.63 Million in Sales Expected for Steris PLC (STE) This Quarter
www.americanbankingnews.com - March 13 at 8:55 AM
Steris PLC (STE) Given Consensus Rating of "Buy" by AnalystsSteris PLC (STE) Given Consensus Rating of "Buy" by Analysts
www.americanbankingnews.com - March 13 at 1:46 AM
Steris PLC (STE) Expected to Post Earnings of $1.22 Per ShareSteris PLC (STE) Expected to Post Earnings of $1.22 Per Share
www.americanbankingnews.com - March 11 at 4:51 PM
Why Is STERIS (STE) Up 7.7% Since Its Last Earnings Report?Why Is STERIS (STE) Up 7.7% Since Its Last Earnings Report?
finance.yahoo.com - March 9 at 5:45 PM
Richard Martin Steeves Sells 58,953 Shares of Steris PLC (STE) StockRichard Martin Steeves Sells 58,953 Shares of Steris PLC (STE) Stock
www.americanbankingnews.com - March 7 at 6:16 PM
Tamarack Advisers LP Invests $2.19 Million in Steris PLC (STE)Tamarack Advisers LP Invests $2.19 Million in Steris PLC (STE)
www.americanbankingnews.com - March 6 at 10:30 AM
Steris PLC (STE) Shares Sold by Brown Advisory Inc.Steris PLC (STE) Shares Sold by Brown Advisory Inc.
www.americanbankingnews.com - March 4 at 5:03 AM
Steris PLC (STE) Holdings Cut by Schroder Investment Management GroupSteris PLC (STE) Holdings Cut by Schroder Investment Management Group
www.americanbankingnews.com - March 3 at 8:53 AM
Channing Capital Management LLC Has $14.28 Million Holdings in Steris PLC (STE)Channing Capital Management LLC Has $14.28 Million Holdings in Steris PLC (STE)
www.americanbankingnews.com - March 3 at 5:50 AM
Steris PLC (STE) Holdings Lowered by Credit Agricole S ASteris PLC (STE) Holdings Lowered by Credit Agricole S A
www.americanbankingnews.com - March 3 at 5:30 AM
Bank of New York Mellon Corp Acquires 958 Shares of Steris PLC (STE)Bank of New York Mellon Corp Acquires 958 Shares of Steris PLC (STE)
www.americanbankingnews.com - March 3 at 4:42 AM
Snyder Capital Management L P Increases Holdings in Steris PLC (STE)Snyder Capital Management L P Increases Holdings in Steris PLC (STE)
www.americanbankingnews.com - March 2 at 1:57 PM
Carillon Tower Advisers Inc. Invests $4.35 Million in Steris PLC (STE)Carillon Tower Advisers Inc. Invests $4.35 Million in Steris PLC (STE)
www.americanbankingnews.com - March 2 at 5:34 AM
Insider Selling: Steris PLC (STE) Director Sells 2,744 Shares of StockInsider Selling: Steris PLC (STE) Director Sells 2,744 Shares of Stock
www.americanbankingnews.com - March 1 at 10:08 PM
Steris PLC (STE) Position Increased by The Manufacturers Life Insurance Company Steris PLC (STE) Position Increased by The Manufacturers Life Insurance Company
www.americanbankingnews.com - March 1 at 6:04 PM
Steris PLC (STE) Stake Lessened by Sei Investments Co.Steris PLC (STE) Stake Lessened by Sei Investments Co.
www.americanbankingnews.com - February 28 at 5:22 PM
Steris PLC (STE) Director Sells $293,964.30 in StockSteris PLC (STE) Director Sells $293,964.30 in Stock
www.americanbankingnews.com - February 27 at 6:52 PM
Steris PLC (STE) Shares Bought by First Republic Investment Management Inc.Steris PLC (STE) Shares Bought by First Republic Investment Management Inc.
www.americanbankingnews.com - February 27 at 12:48 PM
Rhumbline Advisers Buys 14,410 Shares of Steris PLC (STE)Rhumbline Advisers Buys 14,410 Shares of Steris PLC (STE)
www.americanbankingnews.com - February 27 at 11:26 AM
STERIS Focuses on Expanding Core Business, Competition RifeSTERIS Focuses on Expanding Core Business, Competition Rife
www.zacks.com - February 27 at 9:13 AM
Liberty Mutual Group Asset Management Inc. Lowers Stake in Steris PLC (STE)Liberty Mutual Group Asset Management Inc. Lowers Stake in Steris PLC (STE)
www.americanbankingnews.com - February 27 at 7:32 AM
Steris PLC (STE) Shares Sold by Champlain Investment Partners LLCSteris PLC (STE) Shares Sold by Champlain Investment Partners LLC
www.americanbankingnews.com - February 27 at 5:38 AM
Steris PLC (STE) Shares Bought by BlackRock Inc.Steris PLC (STE) Shares Bought by BlackRock Inc.
www.americanbankingnews.com - February 27 at 4:54 AM
Suntrust Banks Inc. Buys 14,447 Shares of Steris PLC (STE)Suntrust Banks Inc. Buys 14,447 Shares of Steris PLC (STE)
www.americanbankingnews.com - February 26 at 9:38 AM
Arizona State Retirement System Purchases 13,057 Shares of Steris PLC (STE)Arizona State Retirement System Purchases 13,057 Shares of Steris PLC (STE)
www.americanbankingnews.com - February 25 at 4:14 AM
Ex-Dividend Reminder: Allergan, Steris and STAG IndustrialEx-Dividend Reminder: Allergan, Steris and STAG Industrial
www.nasdaq.com - February 23 at 5:09 PM
Steris PLC (STE) to Issue Dividend of $0.31Steris PLC (STE) to Issue Dividend of $0.31
www.americanbankingnews.com - February 22 at 12:06 PM

SEC Filings

STERIS (NYSE:STE) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

STERIS (NYSE:STE) Income Statement, Balance Sheet and Cash Flow Statement

Chart

STERIS (NYSE STE) Stock Chart for Saturday, April, 21, 2018

Loading chart…

This page was last updated on 4/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.